Influence of nicardipine on the pharmacokinetics and pharmacodynamics of propranolol in healthy volunteers
- PMID: 2350528
- PMCID: PMC1380147
- DOI: 10.1111/j.1365-2125.1990.tb03671.x
Influence of nicardipine on the pharmacokinetics and pharmacodynamics of propranolol in healthy volunteers
Abstract
1. The influence of a single oral dose of nicardipine 30 mg on the pharmacokinetics and pharmacodynamics of propranolol 80 mg was investigated in twelve healthy volunteers. 2. Co-administration of nicardipine significantly increased the AUC and the mean Cmax of propranolol. 3. Blood pressure and heart rate tended to decrease more when propranolol and nicardipine were administered together than when propranolol was given alone, but differences are of doubtful significance. 4. The results indicate that nicardipine alters the pharmacokinetics of propranolol by impaired hepatic 'first-pass' clearance, but pharmacodynamics were little affected.
Similar articles
-
Enantioselective inhibitory effect of nicardipine on the hepatic clearance of propranolol in man.Chirality. 1994;6(1):5-10. doi: 10.1002/chir.530060104. Chirality. 1994. PMID: 8018468
-
Influences of the calcium antagonists nicardipine and nifedipine, and the calcium agonist BAY-K-8644, on the pharmacokinetics of propranolol in rats.Cardiovasc Drugs Ther. 1993 Aug;7(4):721-6. doi: 10.1007/BF00877826. Cardiovasc Drugs Ther. 1993. PMID: 7694636
-
Increase in plasma propranolol caused by nicardipine is dependent on the delivery rate of propranolol.Eur J Clin Pharmacol. 1995;49(1-2):121-5. doi: 10.1007/BF00192370. Eur J Clin Pharmacol. 1995. PMID: 8751033
-
Short-term effects of nicardipine and propranolol on ocular and systemic hemodynamics in healthy Japanese subjects.J Clin Pharmacol. 1998 Jan;38(1):68-73. doi: 10.1002/j.1552-4604.1998.tb04379.x. J Clin Pharmacol. 1998. PMID: 9597562 Clinical Trial.
-
Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.Br J Clin Pharmacol. 1991 Mar;31(3):323-32. doi: 10.1111/j.1365-2125.1991.tb05536.x. Br J Clin Pharmacol. 1991. PMID: 2054272 Free PMC article. Clinical Trial.
Cited by
-
Nicardipine does not influence the pharmacokinetics and pharmacodynamics of atenolol.Br J Clin Pharmacol. 1990 Sep;30(3):499-500. doi: 10.1111/j.1365-2125.1990.tb03806.x. Br J Clin Pharmacol. 1990. PMID: 2223431 Free PMC article. Clinical Trial. No abstract available.
-
Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.CNS Drugs. 2017 May;31(5):389-403. doi: 10.1007/s40263-017-0430-3. CNS Drugs. 2017. PMID: 28405886 Review.
-
Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients.Drug Des Devel Ther. 2021 Mar 17;15:1195-1211. doi: 10.2147/DDDT.S297981. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33762817 Free PMC article.
-
Clinical pharmacokinetics of calcium antagonists. An update.Clin Pharmacokinet. 1992 Jun;22(6):416-33. doi: 10.2165/00003088-199222060-00002. Clin Pharmacokinet. 1992. PMID: 1587055 Review.
-
Influence of CYP2D6-dependent metabolism on the steady-state pharmacokinetics and pharmacodynamics of metoprolol and nicardipine, alone and in combination.Br J Clin Pharmacol. 1993 Dec;36(6):531-8. doi: 10.1111/j.1365-2125.1993.tb00411.x. Br J Clin Pharmacol. 1993. PMID: 12959269 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources